Suppressed HIV antibody responses following exposure to antiretrovirals—evidence from PrEP randomized trials and early antiretroviral treatment initiation studies

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (AAI21058-001-01000)
  • U.S. Department of War
  • National Heart, Lung, and Blood Institute (HHSN 75N92019D00032)
  • National Heart, Lung, and Blood Institute (HHSN 75N92019D00033)
  • Gilead Sciences
  • National Institute of Allergy and Infectious Diseases
  • Merck
  • Henry M. Jackson Foundation

This publication has 29 references indexed in Scilit: